Vir Biotechnology Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 20.68 M | $210.71 M | 14.89% | 12.33% |
| ARCH VENTURE MANAGEMENT, LLC | 08/14/2026 | 12.69 M | $129.35 M | -1.72% | 7.57% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 11.50 M | $117.14 M | 24.74% | 6.85% |
| SB INVESTMENT ADVISERS (UK) LTD | 08/14/2026 | 10.95 M | $111.56 M | 0.00% | 6.53% |
| STATE STREET CORP | 08/07/2026 | 9.96 M | $101.53 M | 39.53% | 5.94% |
| GSK PLC | 08/13/2026 | 8.55 M | $87.13 M | 0.00% | 5.10% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 6.39 M | $65.10 M | 18.70% | 3.81% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 5.67 M | $57.74 M | 190.27% | 3.38% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 3.35 M | $34.12 M | 25.98% | 2.00% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 3.12 M | $31.79 M | 20.92% | 1.86% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 2.46 M | $25.03 M | -10.49% | 1.46% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 2.37 M | $24.10 M | -27.23% | 1.41% |
| FMR LLC | 08/13/2026 | 2.32 M | $23.62 M | 11.90% | 1.38% |
| MORGAN STANLEY | 08/13/2026 | 2.21 M | $22.53 M | -22.53% | 1.32% |
| NUVEEN, LLC | 08/11/2026 | 1.98 M | $20.21 M | 94.60% | 1.18% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 1.95 M | $19.90 M | 31.91% | 1.16% |
| BOXER CAPITAL MANAGEMENT, LLC | 08/14/2026 | 1.87 M | $19.01 M | 0.00% | 1.11% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.43 M | $14.59 M | 45.33% | 0.85% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 08/14/2026 | 1.36 M | $13.90 M | -7.18% | 0.81% |
| GORDONMD GLOBAL INVESTMENTS LP | 08/14/2026 | 1.35 M | $13.79 M | -10.87% | 0.81% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 1.32 M | $13.48 M | 12.93% | 0.79% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 1.32 M | $13.48 M | 100.00% | 0.79% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 1.14 M | $11.64 M | 18.30% | 0.68% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 1.11 M | $11.31 M | -22.87% | 0.66% |
| SIO CAPITAL MANAGEMENT, LLC | 08/14/2026 | 1.08 M | $10.96 M | -28.25% | 0.64% |
| SAVVY ADVISORS, INC. | 08/03/2026 | 1.04 M | $10.60 M | 100.00% | 0.62% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 1.02 M | $10.36 M | 33.56% | 0.61% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/11/2026 | 1.00 M | $10.19 M | -50.05% | 0.60% |
| CITADEL ADVISORS LLC | 09/02/2026 | 991.34 K | $10.10 M | -52.76% | 0.59% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 08/14/2026 | 853.69 K | $8.70 M | 16.86% | 0.51% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 841.56 K | $8.58 M | 15.01% | 0.50% |
| ENSIGN PEAK ADVISORS, INC | 08/14/2026 | 833.78 K | $8.50 M | -22.14% | 0.50% |
| ALGERT GLOBAL LLC | 08/13/2026 | 804.98 K | $8.20 M | 64.61% | 0.48% |
| JPMORGAN CHASE & CO | 08/12/2026 | 802.60 K | $8.33 M | -28.18% | 0.48% |
| SATURN V CAPITAL MANAGEMENT LLC | 08/14/2026 | 770.64 K | $7.85 M | 100.00% | 0.46% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 694.37 K | $7.08 M | 18.89% | 0.41% |
| JONES HILL CAPITAL LP | 08/13/2026 | 659.21 K | $6.72 M | -44.98% | 0.39% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 653.69 K | $6.66 M | -39.36% | 0.39% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 641.49 K | $6.54 M | -48.63% | 0.38% |
| CANDRIAM S.C.A. | 08/13/2026 | 626.69 K | $6.38 M | -44.82% | 0.37% |
| CLEARSTEAD ADVISORS, LLC | 08/06/2026 | 608.23 K | $6.20 M | -50.00% | 0.36% |
| NORDEA INVESTMENT MANAGEMENT AB | 08/05/2026 | 593.78 K | $6.10 M | 2.24% | 0.35% |
| PRINCIPAL FINANCIAL GROUP INC | 08/04/2026 | 586.90 K | $5.98 M | 7.15% | 0.35% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 581.42 K | $5.92 M | 2.72% | 0.35% |
| WEISS ASSET MANAGEMENT LP | 08/14/2026 | 555.54 K | $5.66 M | 100.00% | 0.33% |
| AVIDITY PARTNERS MANAGEMENT LP | 08/14/2026 | 519.30 K | $5.29 M | -45.34% | 0.31% |
| WALLEYE CAPITAL LLC | 08/03/2026 | 514.25 K | $5.24 M | -22.74% | 0.31% |
| ALTA PARTNERS MANAGEMENT COMPANY, L.P. | 07/22/2026 | 509.92 K | $5.20 M | 0.00% | 0.30% |
| INVESCO LTD. | 08/14/2026 | 475.55 K | $4.85 M | 12.87% | 0.28% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2026 | 475.28 K | $4.84 M | -4.94% | 0.28% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Vir Biotechnology Inc institutional Ownership - FAQ's
During the previous two years, 333 institutional investors and hedge funds held shares of Vir Biotechnology Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 20.68 M
ARCH Venture Management, LLC: 12.69 M
VANGUARD PORTFOLIO MANAGEMENT LLC: 11.5 M
SB INVESTMENT ADVISERS (UK) LTD: 10.95 M
STATE STREET CORP: 9.96 M
GSK PLC: 8.55 M
88.20% of Vir Biotechnology Inc stock is owned by institutional investors.
Institutional investors have bought a total of 181.05 M shares in the last 24 months. This purchase volume represents approximately $1.77 B in transactions.